Altered platelet reactivity, coagulation, endothelial and inflammatory markers early after smoking cessation verified with cotinine plasma concentration

BACKGROUND/INTRODUCTION Cigarette smoking is a potent modifiable risk factor for coronary artery disease (CAD). However, little is known about alterations to prothrombotic state and platelet reactivity early after smoking cessation following percutaneous coronary interventions (PCI). PURPOSE We investigated alterations to platelet reactivity, coagulation and markers of platelet, endothelial, inflammatory and coagulation activation in clopidogrel-treated patients with CAD after PCI before and after smoking cessation. METHODS Smoking patients aged 18 years or older at least 30 days after PCI were recruited and encouraged to quit the habit. At baseline and at 30 days, we measured platelet reactivity with VerifyNow system, thrombomodulin, P-selectin, platelet factor 4 (CXCL4/PF4), citrullinated histone H3 (H3cit) and cotinine level. RESULTS Among 117 patients, 84 patients (72%) at a median age of 60.5 years (40 [interquartile range 30-47] pack-years) completed a 30-day follow-up. At day 30, 30 (35.7%) patients stopped smoking with cotinine level < 50 ng/ml. Baseline characteristics were similar in both groups. In smoking quitters a change in platelet reactivity was larger (Δ platelet reactivity units (PRU) 19 [2, 43] vs. -6 [-32, 37], p = 0.018), along with a change in P-selectin concentration (-11.82 [-23.62, 1.34] vs. 7.19 [-14.24, 17.19] ng/ml, p = 0.005). Positive correlations was noticed between cotinine and both P-selectin ( r = 0.23, p = 0.045) and CXCL4 (r = 0.27, p = 0.02). CONCLUSION After smoking cessation in CAD patients following PCI an increase in platelet reactivity and a decrease in P-selectin levels were observed. The risk of thrombotic complications post PCI might be paradoxically enhanced among patients who stopped smoking.

[1]  A. Budaj,et al.  Smoking and cardiovascular diseases - is there more paradox than expected? , 2019, Polish archives of internal medicine.

[2]  M. Małecki,et al.  Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis , 2019, Cardiovascular Diabetology.

[3]  A. Budaj,et al.  Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study , 2019, Thrombosis and Haemostasis.

[4]  H. Arnesen,et al.  Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease , 2018, European journal of preventive cardiology.

[5]  L. Fu,et al.  Effect of cigarette smoke extract and nicotine on the expression of thrombomodulin and endothelial protein C receptor in cultured human umbilical vein endothelial cells , 2017, Molecular medicine reports.

[6]  T. Helleday,et al.  Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma , 2017, Immunologic research.

[7]  Sungroul Kim.  Overview of Cotinine Cutoff Values for Smoking Status Classification , 2016, International journal of environmental research and public health.

[8]  H. Sung,et al.  Secondhand smoke exposure and serum cotinine levels among current smokers in the USA , 2014, Tobacco Control.

[9]  Peter L Duffy,et al.  Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study , 2013, The Lancet.

[10]  T. Nolin,et al.  The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. , 2013, Journal of the American College of Cardiology.

[11]  H. Crijns,et al.  Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[12]  K. Filipiak,et al.  Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. , 2013, Kardiologia polska.

[13]  E. Florek,et al.  Tobacco smoke exposure and endothelial dysfunction in patients with advanced coronary artery disease. , 2013, Polskie Archiwum Medycyny Wewnetrznej.

[14]  P. Gurbel,et al.  Usefulness of the VerifyNow P2Y12 assay to evaluate the antiplatelet effects of ticagrelor and clopidogrel therapies. , 2012, American heart journal.

[15]  T. Nolin,et al.  Clopidogrel efficacy and cigarette smoking status. , 2012, JAMA.

[16]  Si‐Hyuck Kang,et al.  Enhanced clopidogrel response in smokers is reversed after discontinuation as assessed by VerifyNow assay: additional evidence for the concept of ‘smokers’ paradox' , 2012, Heart.

[17]  Yujie Zhou,et al.  Relationship Between Plasma Inflammatory Markers and Platelet Aggregation in Patients With Clopidogrel Resistance After Angioplasty , 2012, Angiology.

[18]  M. Price,et al.  Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data. , 2011, Journal of the American College of Cardiology.

[19]  R. Polosa,et al.  Circulating endothelial‐coagulative activation markers after smoking cessation: a 12‐month observational study , 2011, European journal of clinical investigation.

[20]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[21]  L. Rauova,et al.  Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. , 2010, Thrombosis research.

[22]  L. Erhardt,et al.  Cigarette smoking: an undertreated risk factor for cardiovascular disease. , 2009, Atherosclerosis.

[23]  M. Tremblay,et al.  The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[24]  B. Baker,et al.  The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. , 2008, Journal of the American College of Cardiology.

[25]  E. Wouters,et al.  Systemic effects of smoking. , 2007, Chest.

[26]  M. Ingelman-Sundberg,et al.  Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans , 2007, European Journal of Clinical Pharmacology.

[27]  P. Whincup,et al.  Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. , 2005, European heart journal.

[28]  Thomas P. Erlinger,et al.  Smoking Cessation and Cardiovascular Disease Risk Factors: Results from the Third National Health and Nutrition Examination Survey , 2005, PLoS medicine.

[29]  Gregory Y H Lip,et al.  The adhesion molecule P-selectin and cardiovascular disease. , 2003, European heart journal.

[30]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[31]  R. Carleton,et al.  Are there gender differences in self-reported smoking practices? Correlation with thiocyanate and cotinine levels in smokers and nonsmokers from the Pawtucket Heart Health Program. , 2002, Journal of women's health.

[32]  S. Goto,et al.  Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. , 1999, Thrombosis research.

[33]  Eichler,et al.  Low‐dose aspirin does not lower in vivo platelet activation in healthy smokers , 1998, British journal of haematology.

[34]  A. Blann,et al.  The influence of smoking on soluble adhesion molecules and endothelial cell markers. , 1997, Thrombosis research.

[35]  J. Hung,et al.  Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. , 1995, Circulation.

[36]  G. Ciabattoni,et al.  Excretion of thromboxane metabolites in healthy women after cessation of smoking. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[37]  M. Shuman,et al.  A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation , 1985, The Journal of cell biology.